Home › Funds › Opaleye Management Inc. › RLMD

Opaleye Management Inc. position in RLMD

RELMADA THERAPEUTICS INC · Health Care

Opaleye Management Inc. reported holding 935,000 shares of RLMD (RELMADA THERAPEUTICS INC) in its Q2 2026 13F filing — a position valued at US$6.5M, representing 0.59% of its reported portfolio and ranking #31 among its reported holdings. Opaleye Management Inc. has disclosed RLMD holdings in 8 of the last 12 reported quarters, going back to Q3 2023.

Latest position (Q2 2026)935.00K sh
Reported value held$6.47M
Portfolio Weight0.59%
First reportedQ3 2023
Last changeHold
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How Opaleye Management Inc.'s RLMD position evolved

Opaleye Management Inc. first disclosed a stake in RLMD in Q3 2023 at 30,000 shares (US$90K). The position peaked in Q1 2026 at 935,000 shares, worth US$6.5M. Across 8 filings, Opaleye Management Inc. increased the stake 1 time(s), trimmed it 3 time(s) and left it unchanged 2 time(s). The most recent filing (Q2 2026) shows 935,000 shares valued at US$6.5M. Notable position changes include a 2823% increase in Q4 2023 (shares rose 12% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 30.00K $90.00K New
Q4 2023 877.00K $3.63M Add
Q1 2024 759.00K $3.53M Reduce
Q2 2024 600.00K $1.80M Reduce
Q3 2024 480.00K $1.56M Reduce
Q4 2025 935.00K $4.52M New
Q1 2026 935.00K $6.51M Hold
Q2 2026 935.00K $6.47M Hold

Dots on the line are colored by change type; missing quarters mean no position was reported.

About RLMD and 13F data

RLMD (RELMADA THERAPEUTICS INC) is a Health Care company. 76 other funds we track also report a position in RLMD — the largest reported positions include Squadron Capital Management LLC (US$50.9M), Venrock Adviser, LLC (US$47.4M), Spruce Street Capital LP (US$44.2M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding RLMD

All RLMD fund holders →

FAQ

How long has Opaleye Management Inc. held RLMD?

Opaleye Management Inc. has disclosed RLMD holdings in 8 of the last 12 reported quarters, going back to Q3 2023.

What is Opaleye Management Inc.'s current position in RLMD?

As of Q2 2026, Opaleye Management Inc. holds 935.00K shares of RLMD (RELMADA THERAPEUTICS INC), valued at $6.47M, representing 0.59% of its reported portfolio and ranking #31.

Has Opaleye Management Inc. been buying or selling RLMD?

In the latest 13F filing (Q2 2026), Opaleye Management Inc. held unchanged its position in RLMD. The position peaked in Q1 2026 at 935.00K shares.

Which other funds hold RLMD?

Other major institutional holders of RLMD include Squadron Capital Management LLC, Venrock Adviser, LLC, Spruce Street Capital LP, among 76 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.